The key risk is conversion, not reactor science. NuScale has a real regulatory asset, low software commoditization exposure, and useful supply-chain progress, but 2031 value still hinges on a few externally gated events: a
TVA/
ENTRA1 PPA,
OEM contracting,
RoPower financing, and proof that NuScale keeps enough licensing and lifecycle economics after partners, suppliers, and
dilution take their share.